Real-time enrollment status for this based on the limited information provided, i cannot determine the primary patient-facing medical condition from this clinical trial data. the study title only mentions it's evaluating the safety of pirtobrutinib, and the conditions section only lists "drug:pirtobrutinib" which is not a medical condition. without additional context about what condition this drug treats, i cannot provide the requested output. clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 8:37 PM UTC
| NCT Number | NCT06876649 |
| Recruiting Status | Recruiting |
| Condition | Based on the limited information provided, I cannot determine the primary patient-facing medical condition from this clinical trial data. The study title only mentions it's evaluating the safety of Pirtobrutinib, and the conditions section only lists "DRUG:Pirtobrutinib" which is not a medical condition. Without additional context about what condition this drug treats, I cannot provide the requested output. |
| Phase | PHASE4 |
| Target Enrollment | 787 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | March 2, 2026 (Mar 2, 2026) |
As of July 16, 2026: Clinical trial NCT06876649 is currently recruiting participants. This phase4 study for based on the limited information provided, i cannot determine the primary patient-facing medical condition from this clinical trial data. the study title only mentions it's evaluating the safety of pirtobrutinib, and the conditions section only lists "drug:pirtobrutinib" which is not a medical condition. without additional context about what condition this drug treats, i cannot provide the requested output. is actively seeking new participants at 20 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06876649 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06876649 was last updated Mar 2, 2026 (March 2, 2026). HelloStudys verifies this status automatically.